Both in Biotechnology
Novavax vs Hemab Therapeutics Holdings
Over the past year NVAX returned +7.0% and COAG returned +5.2%; their daily moves had a correlation of 0.25.
NVAX +7.0% COAG +5.2%Growth of $1, one year, split-adjusted
| Metric | NVAX | COAG |
|---|---|---|
| Price | $10.08 | $41.45 |
| Market cap | $1.66B | $1.94B |
| Today | −3.72% | +2.55% |
| 1 month | −4.9% | +33.5% |
| 6 months | +25.4% | — |
| Year to date | +50.0% | — |
| 1 year | +20.3% | — |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 74.9% | — |
| Net margin | −94.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | — |
| Net cash | $422.0M | $457.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.8% | — |
| Short % of float | 30.3% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).